Jazz Pharmaceuticals (JAZZ) Change in Cash (2010 - 2026)

Jazz Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at $452.4 million for Q1 2026.

• On a quarterly basis, Change in Cash rose 182.11% year-over-year to $452.4 million in Q1 2026; TTM through Mar 2026 was -$17.6 million, a 104.2% decrease from a year earlier, with the FY2025 full-year figure at -$1.0 billion, down 212.62% from the prior year.
• Change in Cash grew to $452.4 million in Q1 2026 per JAZZ's latest filing, from $65.8 million in the prior quarter.
• Across five years, Change in Cash topped out at $862.3 million in Q3 2024 and bottomed at -$672.0 million in Q2 2025.
• The 5-year median for Change in Cash is $114.4 million (2023), against an average of $73.7 million.
• Across the five-year window, Change in Cash soared 1515.28% in 2024 and sank 775.65% in 2025, its largest moves.
• Year by year, Change in Cash stood at $42.1 million in 2022, then surged by 305.04% to $170.6 million in 2023, then increased by 14.13% to $194.7 million in 2024, then sank by 66.19% to $65.8 million in 2025, then surged by 587.24% to $452.4 million in 2026.
• Per Business Quant, the three latest JAZZ Change in Cash figures stand at $452.4 million (Q1 2026), $65.8 million (Q4 2025), and $136.2 million (Q3 2025).